Comparison of clinical and metabolic effects of pasireotide and pituitary surgery in Cushing disease

Risultato della ricerca: Other

Abstract

Pituitary surgery represents the first-line treatment for most patients with Cushing’s disease (CD). In the case of surgery failure, additional treatment options are required. Pasireotide has shown favourable results in the first-line treatment of patients with CD, who are not candidates for surgery or in the second-line when surgery has failed. The aim of the current study is to compare the effects of surgery and pasireotide treatment in a cohort of patients with CD, and to evaluate the differences in response rate in terms of hormonal and clinical control, and improvement of metabolic complications.
Lingua originaleEnglish
Pagine190-190
Numero di pagine1
Stato di pubblicazionePublished - 2017

    Fingerprint

Cita questo